Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Stop Osteoarthritis (SOAR) Hybrid Effectiveness-Implementation Type 1 Randomized Controlled Trial for Young People At-High-Risk of Early Onset Knee Osteoarthritis

NCT06195423 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06195423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06195423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Stop Osteoarthritis (SOAR) Hybrid Effectiveness-Implementation Type 1 Randomized Controlled Trial for Young People At-High-Risk of Early Onset Knee Osteoarthritis
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2024
Completion date
December 30, 2028
Enrollment
210 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament rupture, knee injuries, osteoarthritis, knee